SCHEMBL20207110

SCHEMBL20207110

COC(=O)c1ccnc(-c2cnn3ccc(-c4ccccc4)nc23)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JMJD6 Q6NYC1 1/20 0.49
CAMK2D Q13557 8/20 0.49
KCNH2 Q12809 2/20 0.49
KDM4E B2RXH2 1/20 0.48
KDM6B O15054 1/20 0.48
KDM5C P41229 1/20 0.48
KDM4C Q9H3R0 1/20 0.48
KDM2A Q9Y2K7 1/20 0.48
KDM3A Q9Y4C1 1/20 0.48
PIK3CD O00329 1/20 0.47
CAMKK1 Q8N5S9 1/20 0.47
CAMKK2 Q96RR4 1/20 0.47
ALDH1A2 O94788 1/20 0.45
ALDH1A1 P00352 1/20 0.45
ALDH1A3 P47895 1/20 0.45
GABRG2 P18507 1/20 0.44
GABRB3 P28472 1/20 0.44
GABRA5 P31644 1/20 0.44
GABRA3 P34903 1/20 0.44
NPC1 O15118 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20202106 0.88 CAMK2D (0.50) CAMK2DKCNH2KDM4CPIK3CDCAMKK1
SCHEMBL20202107 0.88 CAMKK1 (0.53) JMJD6CAMK2DKCNH2KDM4EKDM6B
SCHEMBL20207013 0.88 CAMK2D (0.53) CAMK2DKCNH2KDM4CPIK3CDCAMKK1
SCHEMBL20225314 0.86 RET (0.49) CAMK2DKCNH2PIK3CDCAMKK1CAMKK2
SCHEMBL20186375 0.84 CAMK2D (0.68) CAMK2DKCNH2
SCHEMBL20186288 0.81 CAMK2D (0.60) CAMK2DKCNH2PIK3CDCAMKK1CAMKK2
SCHEMBL20186311 0.81 CAMK2D (0.55) CAMK2DKCNH2PIK3CDCAMKK1CAMKK2
SCHEMBL20186826 0.81 CAMK2D (0.60) CAMK2DKCNH2PIK3CDCAMKK1CAMKK2
SCHEMBL20186116 0.81 CAMK2D (0.64) CAMK2DKCNH2EGFRFYN
SCHEMBL20186286 0.81 CAMK2D (0.60) CAMK2DKCNH2PIK3CDCAMKK1CAMKK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3548495-B1 PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS GILEAD SCIENCES INC (US) 2021-01-27 EP disclosed
WO-2018102384-A1 PYRAZOLOPYRIMIDINE DERIVATIVES AS CAM KINASE INHIBITORS GILEAD SCIENCES, INC. (US) 2018-06-07 WO disclosed
US-20180148457-A1 FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS GILEAD SCIENCES, INC. 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180148457-A1 FUSED HETEROCYCLIC COMPOUNDS AS CAM KINASE INHIBITORS CAMK1, CAMKK1, CAMK1D JMJD6 2156/4885CAMK2D 6/4885KCNH2 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.